




Instance: composition-en-eb144117bf1832a81a0b81022c43f19d
InstanceOf: CompositionUvEpi
Title: "Composition for granupas Package Leaflet"
Description:  "Composition for granupas Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp43f22476713f59a3ebfbd3d052873f86)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - granupas"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What GRANUPAS is and what it is used for </li>
<li>What you need to know before you take GRANUPAS </li>
<li>How to take GRANUPAS </li>
<li>Possible side effects </li>
<li>How to store GRANUPAS </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What granupas is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What granupas is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>GRANUPAS contains para-aminosalicylic acid which is used in adults and children aged 28 days and 
older to treat resistant tuberculosis in combination with other medicines, in cases of resistance or 
intolerability with other treatments. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take granupas"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take granupas"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take GRANUPAS 
* if you are allergic to para-aminosalicylic acid or any of the other ingredients of this 
medicine (listed in section 6). 
* if you have severe kidney disease. 
If you are not sure, talk to your doctor or pharmacist before taking GRANUPAS. </p>
<p>Warnings and precautions 
Talk to your doctor or pharmacist before taking GRANUPAS 
* if you have liver problems or mild or moderate kidney disease 
* if you have a stomach ulcer 
* if you are infected with HIV </p>
<p>Children<br />
Use of GRANUPAS is not recommended in newborn babies (under 28 days of age). </p>
<p>Other medicines and GRANUPAS 
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other 
medicines. </p>
<p>It is especially important to tell your doctor if you are taking any of the following: 
* Antituberculosis medicines or ethionamide (other treatments against tuberculosis) 
* Vitamin B* Digoxin (for heart disease) 
* Diphenylhydramine (for allergic reactions) 
* Tenofovir (for HIV/ hepatitis B infections) </p>
<p>Pregnancy and breast-feeding 
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask 
your doctor or pharmacist for advice before taking this medicine. 
GRANUPAS is not recommended during pregnancy and should only be used if advised by your 
physician. 
Do not breastfeed whilst taking GRANUPAS. This is because small amounts of the medicine can 
pass into mother s milk. </p>
<p>Driving and using machines 
GRANUPAS is unlikely to affect your ability to drive any vehicle and use machines. 
In case it does, please report it to your doctor or pharmacist. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take granupas"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take granupas"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist 
if you are not sure. </p>
<p>Adults 
The recommended dose for adults is 1 sachet three times a day, with a schedule of 1 sachet every 
8 hours. Your physician may need to start with a lower dose to prevent possible side effects. 
Do not take more than 3 sachets per day. Treatment is usually given for two years (24 months). </p>
<ul>
<li>Add the contents of the sachet to a drink of tomato or orange juice. </li>
<li>Drink straight away </li>
<li>If some granules are left in the glass, add some more juice and drink straight away. </li>
</ul>
<p>Use in infants, children and adolescents 
The dose in infants, children and adolescents will be calculated by your doctor based on the patient s 
body weight. The recommended total dose per day is 150 mg for each kg of body weight. This daily 
amount is divided into two doses spread out through the day. </p>
<ul>
<li>Use the spoon that comes with the medicine to measure the dose. </li>
<li>To measure the dose: * Lines on the spoon indicate the amount (in milligrams of para-aminosalicylic acid). 
Take the correct amount as prescribed by your doctor. * Put granules directly into the spoon. * Tap the spoon once on a table to give a horizontal level of granules and 
continue filling if necessary. </li>
<li>Sprinkle the granules onto apple sauce or yogurt. </li>
<li>Make your child eat it straight away. </li>
</ul>
<p>Taking this medicine 
* Do not crush or chew the granules. Swallow the granules whole. It is important that you do not 
dissolve, crush or chew the granules as they may not absorb properly and may cause stomach 
ache or bleeding. 
* Do not use the sachet if it is swollen or the granules have lost their light brown colour. 
* You may notice granules appearing in your stools; this is normal. </p>
<p>If you take more GRANUPAS than you should 
Speak to a doctor or pharmacist. </p>
<p>If you forget to take a dose of GRANUPAS 
Do not take a double dose to make up for a forgotten dose. Wait until the next dose is due, then take 
your normal dose. </p>
<p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>During the first 3 months of your treatment with GRANUPAS, you must be attentive to any sign of 
allergic reaction (for example skin eruption, itchy red spots on the skin, itching, rash, watery or itchy 
eyes or stuffy nose) or hepatitis (for example fever, fatigue, dark urine, pale stool, abdominal pain, 
yellow skin and eyes). If you experience any of these symptoms, you must contact to your doctor 
immediately. </p>
<p>Common side effects (may affect more than 1 in 100 people):<br />
<em> giddiness,<br />
</em> stomach ache (abdominal pain),<br />
<em> vomiting,<br />
</em> nausea,<br />
<em> bloating,<br />
</em> diarrhoea,<br />
<em> soft stools,<br />
</em> skin redness or rash,<br />
* disturbance of gait and equilibrium. </p>
<p>Uncommon side effects (may affect more than 1 in 1,000 people):<br />
* loss of appetite (anorexia). </p>
<p>Rare side effects (may affect more than 1 in 10,000 people):<br />
<em> thyroid gland problems</em>,<br />
<em> reduced ability to absorb nutrients from food ulcer,<br />
</em> bleeding in the gut,<br />
<em> yellowing of skin or eyes (jaundice),<br />
</em> metallic taste,<br />
* itchy rash. </p>
<p>(*) in subjects also infected with HIV thyroid gland problems and specifically underactive thyroid or 
low levels of thyroid hormones, are a very common side effect that may affect more than 1 in people. Regular monitoring of the thyroid function is indicated for all people living with HIV. </p>
<p>Very rare side effects (may affect less than 1 in 10,000 people):<br />
<em> reduction in blood platelets, 
* red spots on the skin,<br />
</em> reduction in numbers of white blood cells,<br />
<em> reduction in numbers of red blood cells,<br />
</em> reduction of the ability of red blood cells to release oxygen<br />
<em> low levels of blood sugar,<br />
</em> tendon pain,<br />
<em> headache,<br />
</em> visual abnormalities,<br />
* nerve damage in the hands and feet,  </p>
<ul>
<li>dizziness,  </li>
<li>crystals in urine. </li>
<li>prolonged bleeding time, </li>
<li>destruction of liver cells  </li>
<li>elevated liver enzymes,  </li>
<li>weight loss.  </li>
</ul>
<p>Not known side effects (frequency cannot be estimated from the available data):<br />
* Hepatitis. </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects 
not listed in this leaflet. You can also report side effects directly via the national reporting system 
listed in Appendix V. By reporting side effects you can help provide more information on the safety of 
this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store granupas"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store granupas"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Do not use this medicine after the expiry date which is stated on the carton and sachet after EXP. The 
expiry date refers to the last day of the month. </p>
<p>Do not store above 25 C. The sachets can be stored below 25 C up to 24 hours after opening. </p>
<p>Do not use this medicine if you notice the sachets are swollen or if the granules are dark brown or 
purple. </p>
<p>Do not throw away any medicines via wastewater or household waste.<br />
Ask your pharmacist how to throw away medicines you no longer use. These measures will help 
protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What GRANUPAS contains<br />
The active substance is para-aminosalicylic acid. 
Each sachet of gastro-resistant granules contains 4 g of para-aminosalicylic acid. 
The other ingredients are silica, colloidal hydrated, dibutyl sebacate, methacrylic acid   ethyl acrylate 
copolymer (1:1) dispersion 30 per cent, hypromellose, cellulose, microcrystalline, talc. </p>
<p>What GRANUPAS looks like and contents of the pack 
This medicine is presented as light brown gastro-resistant granules in sachets.<br />
Each box contains 30 sachets. A calibrated measuring spoon is provided. </p>
<p>Marketing Authorisation Holder 
Eurocept International BV 
Trapgans 5 
1244 RL Ankeveen 
The Netherlands </p>
<p>Manufacturer </p>
<p>Eurocept International BV 
Trapgans 5 </p>
<p>1244 RL Ankeveen 
The Netherlands </p>
<p>For any information about this medicine, please contact the local representative of the Marketing 
Authorisation Holder: </p>
<p>Belgi /Belgique/Belgien 
Lucane Pharma 
T l/Tel: + 33 153 868 info@lucanepharma.com 
Lietuva<br />
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com </p>
<p>Lucane Pharma 
Te .: + 33 153 868 info@lucanepharma.com 
Luxembourg/Luxemburg 
Lucane Pharma 
T l/Tel: + 33 153 868 info@lucanepharma.com 
 esk  republika 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Magyarorsz g 
Lucane Pharma 
                 Tel.: + 33 153 868 info@lucanepharma.com 
Danmark 
Lucane Pharma 
Tlf: + 33 153 868 info@lucanepharma.com 
Malta 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Deutschland 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Nederland 
Eurocept International BV 
Tel: +31 35 528 39 info@euroceptpharma.com 
Eesti 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Norge 
Lucane Pharma 
Tlf: + 33 153 868 info@lucanepharma.com </p>
<p>Lucane Pharma 
 : + 33 153 868 info@lucanepharma.com 
 sterreich 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Espa a 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com </p>
<p>Polska 
                  Lucane Pharma 
Tel.: + 33 153 868 info@lucanepharma.com 
France 
Lucane Pharma 
T l: + 33 153 868 info@lucanepharma.com 
Portugal 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Hrvatska 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Rom nia 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com </p>
<p>Ireland 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Slovenija 
                  Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
 sland 
Lucane Pharma 
S mi: + 33 153 868 info@lucanepharma.com 
Slovensk  republika<br />
                      Lucane Pharma 
    Tel: + 33 153 868 info@lucanepharma.com 
Italia 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Suomi/Finland 
Lucane Pharma 
Puh/Tel: + 33 153 868 info@lucanepharma.com </p>
<p>Lucane Pharma 
 : + 33 153 868 info@lucanepharma.com 
Sverige 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Latvija 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
United Kingdom 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com </p>
<p>This leaflet was last revised in  </p>
<p>Other sources of information </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      



Instance: composition-da-eb144117bf1832a81a0b81022c43f19d
InstanceOf: CompositionUvEpi
Title: "Composition for granupas Package Leaflet"
Description:  "Composition for granupas Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mp43f22476713f59a3ebfbd3d052873f86)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - granupas"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen </p>
<ol>
<li>Virkning og anvendelse </li>
<li>Det skal du vide, før du begynder at tage GRANUPAS </li>
<li>Sådan skal du tage GRANUPAS </li>
<li>Bivirkninger </li>
<li>Opbevaring </li>
<li>Pakningsstørrelser og yderligere oplysninger </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What granupas is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What granupas is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>GRANUPAS indeholder para-aminosalicylsyre, der anvendes i kombination med andre lægemidler 
hos voksne og børn over 28 dage til behandling af tuberkulose i tilfælde af resistens eller intolerans 
over for andre behandlinger.  </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take granupas"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take granupas"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag ikke GRANUPAS: </p>
<ul>
<li>
<p>hvis du er allergisk over for para-aminosalicylsyre eller et af de øvrige indholdsstoffer i 
GRANUPAS (angivet i afsnit 6) </p>
</li>
<li>
<p>hvis du har en alvorlig nyresygdom. 
Hvis du er i tvivl, skal du tale med lægen eller apotekspersonalet, inden du tager GRANUPAS. </p>
</li>
</ul>
<p>Advarsler og forsigtighedsregler 
Kontakt lægen eller apotekspersonalet, før du tager GRANUPAS: </p>
<ul>
<li>
<p>hvis du har leverproblemer eller let til moderat nyresygdom </p>
</li>
<li>
<p>hvis du har mavesår </p>
</li>
<li>
<p>hvis du er smittet med HIV. </p>
</li>
</ul>
<p>Børn 
GRANUPAS frarådes til nyfødte (under 28 dage gamle).  </p>
<p>Brug af anden medicin sammen med GRANUPAS 
Fortæl det altid til lægen eller apotekspersonalet, hvis du bruger anden medicin, har gjort det for nylig 
eller påtænker at gøre det. </p>
<p>Det er særlig vigtigt, at du fortæller det til lægen, hvis du tager noget af følgende:  </p>
<ul>
<li>
<p>Ethionamid eller andre lægemidler mod tuberkulose  </p>
</li>
<li>
<p>Vitamin B* Digoxin (mod hjertesygdom) </p>
</li>
<li>
<p>Diphenhydramin (mod overfølsomhedsreaktioner).  </p>
</li>
<li>
<p>Tenofovir (til HIV/ hepatitis B infektioner) </p>
</li>
</ul>
<p>Graviditet og amning 
Hvis du er gravid eller ammer, har mistanke om, at du er gravid, eller planlægger at blive gravid, skal 
du spørge lægen eller apotekspersonalet til råds, før du bruger dette lægemiddel. 
GRANUPAS anbefales ikke under graviditet og må kun bruges, hvis din læge tilråder det. 
Du må ikke amme, mens du tager GRANUPAS. Dette skyldes, at små mængder af lægemidlet kan gå 
over i modermælken.  </p>
<p>Trafik- og arbejdssikkerhed 
GRANUPAS forventes ikke at påvirke din evne til at føre køretøj eller betjene maskiner. 
Hvis det gør, fortæl det venligst til din læge eller på apoteket. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take granupas"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take granupas"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Brug altid dette lægemiddel nøjagtigt efter lægens anvisning. Er du i tvivl, så spørg lægen eller på 
apoteket. </p>
<p>Voksne: 
Den anbefalede dosis til voksne er 1 brev tre gange dagligt, fordelt med 1 brev hver 8. time. Lægen 
kan finde det nødvendigt at begynde med en lavere dosis for at undgå eventuelle bivirkninger.<br />
Tag ikke mere end 3 breve dagligt. Behandlingstiden er sædvanligvis to år (24 måneder).  </p>
<ul>
<li>
<p>Tilsæt indholdet i brevet til et glas tomat- eller appelsinjuice. </p>
</li>
<li>
<p>Drik det med det samme.  </p>
</li>
<li>
<p>Hvis der er granulat tilbage i glasset, skal du tilsætte mere juice og drikke det med det samme. </p>
</li>
</ul>
<p>Brug til spædbørn, børn og unge<br />
Dosis til spædbørn, børn og unge vil af lægen blive beregnet ud fra patientens legemsvægt. Den 
anbefalede daglige totaldosis er 150 mg pr. kg legemsvægt. Den daglige mængde skal gives som to 
doser, der fordeles over døgnet.  </p>
<ul>
<li>
<p>Brug den medfølgende ske til at måle dosis.  </p>
</li>
<li>
<p>Måling af dosis:  * Linjerne på skeen angiver mængden (i milligram para-aminosalicylsyre). Tag den 
mængde, lægen har ordineret.  * Hæld granulatet direkte i skeen.  * Bank skeen let mod bordet, så overfladen af granulatet bliver vandret, og fyld efter om 
nødvendigt. </p>
</li>
<li>
<p>Drys granulatet på æblemos eller yoghurt.  </p>
</li>
<li>
<p>Få barnet til at spise det med det samme. </p>
</li>
</ul>
<p>Brug af lægemidlet </p>
<ul>
<li>
<p>Undlad at knuse eller tygge granulatet. Slug granulatet helt. Det er vigtigt, at du ikke opløser, 
knuser eller tygger granulatet, da det måske ikke vil blive absorberet korrekt og kan give 
mavesmerter eller maveblødning. </p>
</li>
<li>
<p>Brug ikke brevet, hvis det er svulmet op, eller hvis granulatet har mistet sin lysebrune farve.  </p>
</li>
<li>
<p>Du vil kunne se rester af granulatet i afføringen; dette er normalt.  </p>
</li>
</ul>
<p>Hvis du har taget for meget GRANUPAS 
Tal med lægen eller apotekspersonalet.  </p>
<p>Hvis du har glemt at tage en dosis GRANUPAS 
Du må ikke tage en dobbeltdosis som erstatning for den glemte dosis. Vent, til du skal have næste 
dosis, og tag så den normale dosis. 
Spørg lægen eller på apoteket, hvis der er mere, du vil vide om brugen af lægemidlet. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som al anden medicin give bivirkninger, men ikke alle får bivirkninger. </p>
<p>I løbet af de første tre måneder af behandlingen med GRANUPAS skal du være opmærksom på 
ethvert tegn på overfølsomhedsreaktion (såsom hududslæt, kløende røde pletter på huden, kløe, 
udslæt, øjne der løber i vand eller klør, tilstoppet næse) eller leverbetændelse (såsom feber, træthed, 
mørk urin, bleg afføring, mavesmerter, gul hud og øjne). Hvis du kommer ud for nogen af disse 
symptomer, skal du straks kontakte lægen. </p>
<p>Almindelige bivirkninger (forekommer hos mere end 1 ud af 100 behandlede):  </p>
<ul>
<li>
<p>svimmelhed,  </p>
</li>
<li>
<p>mavesmerter,  </p>
</li>
<li>
<p>opkastning,  </p>
</li>
<li>
<p>kvalme,  </p>
</li>
<li>
<p>oppustethed,  </p>
</li>
<li>
<p>diarré,  </p>
</li>
<li>
<p>blød afføring,  </p>
</li>
<li>
<p>rødme eller hududslæt,  </p>
</li>
<li>
<p>gang- eller ligevægtsforstyrrelser. </p>
</li>
</ul>
<p>Ikke almindelige bivirkninger (forekommer hos mere end 1 ud af 1 000 behandlede):  </p>
<ul>
<li>nedsat appetit (anoreksi).  </li>
</ul>
<p>Sjældne bivirkninger (forekommer hos mere end 1 ud af 10 000 behandlede):  </p>
<ul>
<li>
<p>problemer med skjoldbruskkirtlen*,  </p>
</li>
<li>
<p>nedsat evne til at optage næringsstoffer fra føden,  </p>
</li>
<li>
<p>mavesår,  </p>
</li>
<li>
<p>tarmblødning,  </p>
</li>
<li>
<p>gulfarvning af hud eller øjne,  </p>
</li>
<li>
<p>metalsmag,  </p>
</li>
<li>
<p>kløende udslæt.  </p>
</li>
</ul>
<p>(*) hos personer,der også er smittet med HIV og har problemer med skjoldbruskkirtlen specielt en 
underaktiv skjoldbruskkirtel eller som har lave niveauer af skjoldbruskkirtlens hormoner, er det en 
meget almindelig bivirkning, der kan påvirke mere end 1 af 10 personer. En regelmæssig overvågning 
af skjoldbruskkirtlens funktion er indiceret hos personer, som lever med HIV. </p>
<p>Meget sjældne bivirkninger (forekommer hos mindre end 1 ud af 10 000 behandlede):  </p>
<ul>
<li>
<p>nedsat antal blodplader,  </p>
</li>
<li>
<p>røde pletter på huden,  </p>
</li>
<li>
<p>nedsat antal hvide blodlegemer, </p>
</li>
<li>
<p>nedsat antal røde blodlegemer, </p>
</li>
<li>
<p>reduktion af de røde blodlegemers evne til at frigive ilt, </p>
</li>
<li>
<p>lavt blodsukker,  </p>
</li>
<li>
<p>senesmerter, hovedpine,  </p>
</li>
<li>
<p>synsforstyrrelser,  </p>
</li>
<li>
<p>nervebeskadigelse i hænder og fødder,  </p>
</li>
<li>
<p>svimmelhed,  </p>
</li>
<li>
<p>krystaller i urinen. </p>
</li>
<li>
<p>forlænget blødningstid,  </p>
</li>
<li>
<p>destruktion af leverceller, </p>
</li>
<li>
<p>forhøjede leverenzymer,  </p>
</li>
<li>
<p>vægttab,  </p>
</li>
</ul>
<p>Ikke kendt bivirkninger (kan ikke estimeres ud fra forhåndenværende data): </p>
<ul>
<li>hepatitis </li>
</ul>
<p>Indberetning af bivirkninger 
Hvis du oplever bivirkninger, skal du sige det til lægen eller på apoteket. Dette gælder også 
bivirkninger, der ikke fremgår af denne indlægsseddel. Du kan desuden indberette bivirkninger direkte 
til Sundhedsstyrelsen via det nationale rapporteringssystem anført i Appendiks V. Ved at indberette 
bivirkninger kan du medvirke til at skaffe flere oplysninger om sikkerheden af dette lægemiddel.  </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store granupas"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store granupas"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Opbevares lægemidlet utilgængeligt for børn. </p>
<p>Brug ikke lægemidlet efter den udløbsdato, der står på kartonen og på brevet efter EXP. Udløbsdatoen 
er den sidste dag i den nævnte måned. </p>
<p>Må ikke opbevares over 25º C. Brevene kan opbevares ved temperaturer under 25 °C i op til 24 timer, 
efter at de er åbnet.  </p>
<p>Brug ikke lægemidlet, hvis du bemærker, at brevene er opsvulmede, eller hvis granulatet er 
mørkebrunt eller violet. </p>
<p>Spørg på apoteket, hvordan du skal bortskaffe medicinrester. Af hensyn til miljøet må du ikke smide 
medicinrester i afløbet, eller toilettet eller skraldespanden. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>GRANUPAS indeholder:<br />
Det aktive stof er para-aminosalicylsyre. 
Hvert brev enterogranulat indeholder 4 g para-aminosalicylsyre. </p>
<p>De øvrige indholdsstoffer er kolloid silica, methacrylsyre-ethylacrylat copolymer (1:1) dispersion 
30 %, hypromellose, mikrokrystallinsk cellulose, talcum.  </p>
<p>Udseende og pakningsstørrelser 
Lægemidlet er et lysebrunt enterogranulat i breve.<br />
Hver karton indeholder 30 breve. Der medfølger en kalibreret måleske. </p>
<p>Indehaver af markedsføringstilladelsen 
Eurocept International BV 
Trapgans 5 
1244 RL Ankeveen 
Holland </p>
<p>Fremstiller 
Eurocept International BV 
Trapgans 5 
1244 RL Ankeveen 
Holland </p>
<p>Hvis du ønsker yderligere oplysninger om dette lægemiddel, skal du henvende dig til den lokale 
repræsentant for indehaveren af markedsføringstilladelsen: </p>
<p>België/Belgique/Belgien 
Lucane Pharma 
Tél/Tel: + 33 153 868 info@lucanepharma.com </p>
<p>Lietuva 
FrostPharma AB 
Tel: +46 775 86 80 info@frostpharma.com </p>
<p>България 
Lucane Pharma 
Teл.: + 33 153 868 info@lucanepharma.com </p>
<p>Luxembourg/Luxemburg 
Lucane Pharma 
Tél/Tel: + 33 153 868 info@lucanepharma.com 
Česká republika 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Magyarország 
Lucane Pharma 
Tel.: + 33 153 868 info@lucanepharma.com 
Danmark 
FrostPharma AB 
Tlf: +46 775 86 80 info@frostpharma.com </p>
<p>Malta 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Deutschland 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com </p>
<p>Nederland 
Eurocept International BV 
Tel: +31 35 528 39 info@euroceptpharma.com 
Eesti 
FrostPharma AB 
Tel: +46 775 86 80 info@frostpharma.com </p>
<p>Norge 
FrostPharma AB 
Tlf: +46 775 86 80 info@frostpharma.com </p>
<p>Ελλάδα 
Lucane Pharma 
Τηλ: + 33 153 868 info@lucanepharma.com </p>
<p>Österreich 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
España 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com </p>
<p>Polska 
Lucane Pharma 
Tel.: + 33 153 868 info@lucanepharma.com 
France 
Lucane Pharma 
Tél: + 33 153 868 info@lucanepharma.com </p>
<p>Portugal 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Hrvatska 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com </p>
<p>România 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com </p>
<p>Ireland 
Lucane Pharma 
Tel: + 33 153 868 Slovenija 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com </p>
<p>info@lucanepharma.com 
Ísland 
FrostPharma AB 
Sími: +46 775 86 80 info@frostpharma.com </p>
<p>Slovenská republika 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Italia 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com 
Suomi/Finland 
FrostPharma AB 
Puh/Tel: +46 775 86 80 info@frostpharma.com </p>
<p>Κύπρος 
Lucane Pharma 
Τηλ: + 33 153 868 info@lucanepharma.com </p>
<p>Sverige 
FrostPharma AB 
Tel: +46 775 86 80 info@frostpharma.com </p>
<p>Latvija 
FrostPharma AB 
Tel: +46 775 86 80 info@frostpharma.com </p>
<p>United Kingdom 
Lucane Pharma 
Tel: + 33 153 868 info@lucanepharma.com </p>
<p>Denne indlægsseddel blev senest ændret i  </p>
<p>Andre informationskilder </p>
<p>Du kan finde yderligere oplysninger om dette lægemiddel på Det Europæiske Lægemiddelagenturs 
hjemmeside: http://www.ema.europa.eu. 
Der er også links til andre hjemmesider om sjældne sygdomme og om, hvordan de behandles. </p>         </div>"""      





                    
Instance: bundlepackageleaflet-en-eb144117bf1832a81a0b81022c43f19d
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for granupas Package Leaflet for language en"
Description: "ePI document Bundle for granupas Package Leaflet for language en"
Usage: #example




* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-eb144117bf1832a81a0b81022c43f19d"
* entry[0].resource = composition-en-eb144117bf1832a81a0b81022c43f19d

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mpeb144117bf1832a81a0b81022c43f19d"
* entry[=].resource = mpeb144117bf1832a81a0b81022c43f19d
                            
                    
Instance: bundlepackageleaflet-da-eb144117bf1832a81a0b81022c43f19d
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for granupas Package Leaflet for language da"
Description: "ePI document Bundle for granupas Package Leaflet for language da"
Usage: #example




* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-eb144117bf1832a81a0b81022c43f19d"
* entry[0].resource = composition-da-eb144117bf1832a81a0b81022c43f19d

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mpeb144117bf1832a81a0b81022c43f19d"
* entry[=].resource = mpeb144117bf1832a81a0b81022c43f19d
                            
                    



Instance: mpeb144117bf1832a81a0b81022c43f19d
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product granupas"
Description: "granupas"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/13/896/001"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"


* indication = "GRANUPAS is indicated for use as part of an appropriate combination regimen for multi-drug"


* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"


* name
  * productName = "granupas"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#DK "DK"
    * jurisdiction = urn:iso:std:iso:3166#DK "DK"
    * language = urn:ietf:bcp:47#en  "en"




RuleSet: eb144117bf1832a81a0b81022c43f19dListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "granupas"

* status = #current
* mode = #working

* title = "List of all ePIs associated with granupas"

* subject = Reference(mp43f22476713f59a3ebfbd3d052873f86)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#granupas "granupas"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-eb144117bf1832a81a0b81022c43f19d) // granupas en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-eb144117bf1832a81a0b81022c43f19d) // granupas da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-eb144117bf1832a81a0b81022c43f19d
InstanceOf: List

* insert eb144117bf1832a81a0b81022c43f19dListRuleset
    